NCT02381158View on ClinicalTrials.gov

Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Wheezing
Interventions
DRUG

Nebulized beclomethasone dipropionate

Nebulized beclomethasone dipropionate applied for 12 weeks with a dose of 400 µg twice a day (total dose 800 µg)

All Listed Sponsors
lead

Istituto per la Ricerca e l'Innovazione Biomedica

OTHER

NCT02381158 - Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing | Biotech Hunter | Biotech Hunter